BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: González N, Prieto I, Del Puerto-Nevado L, Portal-Nuñez S, Ardura JA, Corton M, Fernández-Fernández B, Aguilera O, Gomez-Guerrero C, Mas S, Moreno JA, Ruiz-Ortega M, Sanz AB, Sanchez-Niño MD, Rojo F, Vivanco F, Esbrit P, Ayuso C, Alvarez-Llamas G, Egido J, García-Foncillas J, Ortiz A; DiabetesCancerConnect Consortium. 2017 update on the relationship between diabetes and colorectal cancer: epidemiology, potential molecular mechanisms and therapeutic implications. Oncotarget 2017;8:18456-85. [PMID: 28060743 DOI: 10.18632/oncotarget.14472] [Cited by in Crossref: 65] [Cited by in F6Publishing: 66] [Article Influence: 13.0] [Reference Citation Analysis]
Number Citing Articles
1 Taskoparan B, Seza EG, Demirkol S, Tuncer S, Stefek M, Gure AO, Banerjee S. Opposing roles of the aldo-keto reductases AKR1B1 and AKR1B10 in colorectal cancer. Cell Oncol (Dordr) 2017;40:563-78. [PMID: 28929377 DOI: 10.1007/s13402-017-0351-7] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 3.8] [Reference Citation Analysis]
2 Elangovan A, Skeans J, Landsman M, Ali SMJ, Elangovan AG, Kaelber DC, Sandhu DS, Cooper GS. Colorectal Cancer, Age, and Obesity-Related Comorbidities: A Large Database Study. Dig Dis Sci 2021;66:3156-63. [DOI: 10.1007/s10620-020-06602-x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
3 Deng P, Zhou Y, Wang X, Tang K, Jiang H, He W, Zheng H, Zhao L, Gao H, Li C. The Protective Effect of Basic Fibroblast Growth Factor in Intestine of db/db Mice: A 1H NMR-Based Metabolomics Investigation. J Proteome Res 2021;20:5024-35. [PMID: 34699241 DOI: 10.1021/acs.jproteome.1c00519] [Reference Citation Analysis]
4 Sacerdote C, Ricceri F. Epidemiological dimensions of the association between type 2 diabetes and cancer: A review of observational studies. Diabetes Res Clin Pract. 2018;. [PMID: 29596949 DOI: 10.1016/j.diabres.2018.03.002] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 3.8] [Reference Citation Analysis]
5 Rennert G, Rennert HS, Gronich N, Pinchev M, Gruber SB. Use of metformin and risk of breast and colorectal cancer. Diabetes Res Clin Pract 2020;165:108232. [PMID: 32446797 DOI: 10.1016/j.diabres.2020.108232] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
6 Zhang X, Li X, He Y, Law PJ, Farrington SM, Campbell H, Tomlinson IPM, Houlston RS, Dunlop MG, Timofeeva M, Theodoratou E. Phenome-wide association study (PheWAS) of colorectal cancer risk SNP effects on health outcomes in UK Biobank. Br J Cancer 2021. [PMID: 34912076 DOI: 10.1038/s41416-021-01655-9] [Reference Citation Analysis]
7 Chakraborty D, Jin W, Wang J. The bifurcated role of adiponectin in colorectal cancer. Life Sci 2021;278:119524. [PMID: 33887344 DOI: 10.1016/j.lfs.2021.119524] [Reference Citation Analysis]
8 Piper MS, Saad RJ. Diabetes Mellitus and the Colon. Curr Treat Options Gastroenterol. 2017;15:460-474. [PMID: 29063998 DOI: 10.1007/s11938-017-0151-1] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 4.6] [Reference Citation Analysis]
9 Ahechu P, Zozaya G, Martí P, Hernández-Lizoáin JL, Baixauli J, Unamuno X, Frühbeck G, Catalán V. NLRP3 Inflammasome: A Possible Link Between Obesity-Associated Low-Grade Chronic Inflammation and Colorectal Cancer Development. Front Immunol 2018;9:2918. [PMID: 30619282 DOI: 10.3389/fimmu.2018.02918] [Cited by in Crossref: 40] [Cited by in F6Publishing: 40] [Article Influence: 10.0] [Reference Citation Analysis]
10 May S, Parry C, Parry L. Berry chemoprevention: Do berries decrease the window of opportunity for tumorigenesis. Food Frontiers 2020;1:260-75. [DOI: 10.1002/fft2.32] [Cited by in Crossref: 5] [Article Influence: 2.5] [Reference Citation Analysis]
11 Christensen JF, Sundberg A, Osterkamp J, Thorsen-Streit S, Nielsen AB, Olsen CK, Djurhuus SS, Simonsen C, Schauer T, Ellingsgaard H, Østerlind K, Krarup PM, Mosgaard C, Vistisen K, Tolver A, Pedersen BK, Hojman P. Interval Walking Improves Glycemic Control and Body Composition After Cancer Treatment: A Randomized Controlled Trial. J Clin Endocrinol Metab 2019;104:3701-12. [PMID: 31220283 DOI: 10.1210/jc.2019-00590] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
12 Mo X, Su Z, Yang B, Zeng Z, Lei S, Qiao H. Identification of key genes involved in the development and progression of early-onset colorectal cancer by co-expression network analysis. Oncol Lett 2020;19:177-86. [PMID: 31897128 DOI: 10.3892/ol.2019.11073] [Cited by in Crossref: 7] [Cited by in F6Publishing: 10] [Article Influence: 2.3] [Reference Citation Analysis]
13 Petimar J, Tabung FK, Valeri L, Rosner B, Chan AT, Smith-Warner SA, Giovannucci EL. Mediation of associations between adiposity and colorectal cancer risk by inflammatory and metabolic biomarkers. Int J Cancer 2019;144:2945-53. [PMID: 30521066 DOI: 10.1002/ijc.32047] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
14 He D, Yue Z, Liu L, Fang X, Chen L, Han H. Long noncoding RNA ABHD11-AS1 promote cells proliferation and invasion of colorectal cancer via regulating the miR-1254-WNT11 pathway. J Cell Physiol 2019;234:12070-9. [PMID: 30537177 DOI: 10.1002/jcp.27877] [Cited by in Crossref: 12] [Cited by in F6Publishing: 15] [Article Influence: 3.0] [Reference Citation Analysis]
15 Wang B, Wang S, Wang W, Liu E, Guo S, Zhao C, Niu J, Zhang Z. Hyperglycemia Promotes Liver Metastasis of Colorectal Cancer via Upregulation of Integrin αvβ6. Med Sci Monit 2021;27:e930921. [PMID: 34408123 DOI: 10.12659/MSM.930921] [Reference Citation Analysis]
16 Hevroni G, Skwiersky S, Zhyvotovska A, McFarlane SI. Metformin use and the Risk of Gastrointestinal Malignancies in Diabetic Populations: A Meta-Analysis. Int J Clin Endocrinol Metab 2020;6:035-41. [PMID: 33604594 DOI: 10.17352/ijcem.000052] [Reference Citation Analysis]
17 de Haan-Du J, Landman GWD, Kleefstra N, Schrijnders D, Manders M, Bos ACRK, Tromp-van Driel C, Denig P, Groenier KH, de Bock GH. Glycemic Control for Colorectal Cancer Survivors Compared to Those without Cancer in the Dutch Primary Care for Type 2 Diabetes: A Prospective Cohort Study. Cancers (Basel) 2021;13:2767. [PMID: 34199595 DOI: 10.3390/cancers13112767] [Reference Citation Analysis]
18 Fucarino A, Pitruzzella A. Role of HSP60/HSP10 in Lung Cancer: Simple Biomarkers or Leading Actors? J Oncol 2020;2020:4701868. [PMID: 32318107 DOI: 10.1155/2020/4701868] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
19 Azzam N, AlRuthia Y, Alharbi O, Aljebreen A, Almadi M, Alarfaj M, Alsaleh K, Almasoud A, Alsharidah M, Alseneidi S, Alali F, Alalwan M. Predictors of Survival Among Colorectal Cancer Patients in a Low Incidence Area. Cancer Manag Res 2020;12:451-9. [PMID: 32021457 DOI: 10.2147/CMAR.S233215] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
20 Broadfield LA, Saigal A, Szamosi JC, Hammill JA, Bezverbnaya K, Wang D, Gautam J, Tsakiridis E, Di Pastena F, McNicol J, Wu J, Syed S, Lally JSV, Raphenya AR, Blouin MJ, Pollak M, Sacconi A, Blandino G, McArthur AG, Schertzer JD, Surette M, Collins SM, Bramson JL, Muti P, Tsakiridis T, Steinberg GR. Metformin-induced reductions in tumor growth involves modulation of the gut microbiome. Mol Metab 2022;:101498. [PMID: 35452877 DOI: 10.1016/j.molmet.2022.101498] [Reference Citation Analysis]
21 Yue X, Han T, Hao W, Wang M, Fu Y. SHP2 knockdown ameliorates liver insulin resistance by activating IRS-2 phosphorylation through the AKT and ERK1/2 signaling pathways. FEBS Open Bio 2020;10:2578-87. [PMID: 33012117 DOI: 10.1002/2211-5463.12992] [Reference Citation Analysis]
22 Silva RMSD, Collaço PMC, Cunha KS, Dias EP. Diagnosis of Advanced Disease in Cases of Colorectal Cancer in a Developing Country. Journal of Coloproctology. [DOI: 10.1055/s-0041-1736517] [Reference Citation Analysis]
23 Rastad H, Parsaeian M, Shirzad N, Mansournia MA, Yazdani K. Diabetes mellitus and cancer incidence: the Atherosclerosis Risk in Communities (ARIC) cohort study. J Diabetes Metab Disord 2019;18:65-72. [PMID: 31275876 DOI: 10.1007/s40200-019-00391-5] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.7] [Reference Citation Analysis]
24 Chang VC, Cotterchio M, De P, Tinmouth J. Risk factors for early-onset colorectal cancer: a population-based case-control study in Ontario, Canada. Cancer Causes Control 2021. [PMID: 34120288 DOI: 10.1007/s10552-021-01456-8] [Reference Citation Analysis]
25 Zeng X, Li Z, Zhu C, Xu L, Sun Y, Han S. Research progress of nanocarriers for gene therapy targeting abnormal glucose and lipid metabolism in tumors. Drug Deliv 2021;28:2329-47. [PMID: 34730054 DOI: 10.1080/10717544.2021.1995081] [Reference Citation Analysis]
26 Islam R, Khan R, Ali A, Kollu V, Phan T, Chyou PH, Burmester JK, Kibriya MG. Clinical Factors Affecting Bevacizumab Efficacy With and Without Conventional Chemotherapy in Metastatic Colon Cancer. Am J Ther 2020;27:e500-6. [PMID: 32902937 DOI: 10.1097/MJT.0000000000000859] [Reference Citation Analysis]
27 Zhang T, Jin Y, Jiang X, Li L, Qi X, Mao Y, Hua D. Clinical and Prognostic Relevance of B7-H3 and Indicators of Glucose Metabolism in Colorectal Cancer. Front Oncol 2020;10:546110. [PMID: 33042836 DOI: 10.3389/fonc.2020.546110] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
28 Yu H, Jiang W, Chen G, Yang F, Zhao X, Ji Z, Ni J, Fu Y, Chen F, Zhao B. Impact of Colon-Specific DNA Methylation-Regulated Gene Modules on Colorectal Cancer Patient Survival. Med Sci Monit 2019;25:3549-57. [PMID: 31083646 DOI: 10.12659/MSM.916181] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
29 Otegbeye EE, Fritz CDL, Liao J, Smith RK, Cao Y. Behavioral Risk Factors and Risk of Early-Onset Colorectal Cancer: Review of the Mechanistic and Observational Evidence. Curr Colorectal Cancer Rep 2021;17:43-53. [DOI: 10.1007/s11888-021-00465-8] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
30 El-Sayed NNE, Almaneai NM, Ben Bacha A, El-Ashrey MK, Al-Zaben MI, Almarhoon ZM. Biological Evaluation, Molecular Docking Analyses, and ADME Profiling of Certain New Quinazolinones as Anti-colorectal Agents. ACS Omega 2022;7:18443-58. [PMID: 35694504 DOI: 10.1021/acsomega.2c00812] [Reference Citation Analysis]
31 Malcomson FC. Mechanisms underlying the effects of nutrition, adiposity and physical activity on colorectal cancer risk. Nutr Bull 2018;43:400-15. [DOI: 10.1111/nbu.12359] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.8] [Reference Citation Analysis]
32 Obidike OJ, Rogers CR, Caspi CE. Examining Colorectal Cancer Risk Awareness and Food Shelf Use Among Health Center Patients. J Racial Ethn Health Disparities 2019;6:1021-9. [PMID: 31168698 DOI: 10.1007/s40615-019-00603-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
33 Luo XH, Deng LC, Zhang YF, Huang XR, Chen DF. Application of discharge planning in rectal cancer patients with a stoma. Shijie Huaren Xiaohua Zazhi 2019; 27(7): 435-441 [DOI: 10.11569/wcjd.v27.i7.435] [Reference Citation Analysis]
34 Mrozikiewicz-Rakowska B, Malinowski M, Nehring P, Bartkowiak-Wieczorek J, Bogacz A, Żurawińska-Grzelka E, Krasnodębski P, Muszyński J, Grzela T, Przybyłkowski A, Czupryniak L. The MDR1/ABCB1 gene rs 1045642 polymorphism in colorectal cancer. Arch Med Sci 2020;16:112-7. [PMID: 32051713 DOI: 10.5114/aoms.2017.70329] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
35 Colussi D, Fabbri M, Zagari RM, Montale A, Bazzoli F, Ricciardiello L. Lifestyle factors and risk for colorectal polyps and cancer at index colonoscopy in a FIT-positive screening population. United European Gastroenterol J 2018;6:935-42. [PMID: 30023072 DOI: 10.1177/2050640618764711] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
36 Kotelevets L, Chastre E. Rac1 Signaling: From Intestinal Homeostasis to Colorectal Cancer Metastasis. Cancers (Basel) 2020;12:E665. [PMID: 32178475 DOI: 10.3390/cancers12030665] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
37 Grega T, Vojtechova G, Gregova M, Zavoral M, Suchanek S. Pathophysiological Characteristics Linking Type 2 Diabetes Mellitus and Colorectal Neoplasia. Physiol Res 2021;70:509-22. [PMID: 34062073 DOI: 10.33549/physiolres.934631] [Reference Citation Analysis]
38 Amable G, Martínez-León E, Picco ME, Nemirovsky SI, Rozengurt E, Rey O. Metformin inhibition of colorectal cancer cell migration is associated with rebuilt adherens junctions and FAK downregulation. J Cell Physiol 2020;235:8334-44. [PMID: 32239671 DOI: 10.1002/jcp.29677] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
39 Herold Z, Herold M, Lohinszky J, Dank M, Somogyi A. Personalized Indicator Thrombocytosis Shows Connection to Staging and Indicates Shorter Survival in Colorectal Cancer Patients with or without Type 2 Diabetes. Cancers (Basel) 2020;12:E556. [PMID: 32121060 DOI: 10.3390/cancers12030556] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
40 Herczeg G, Somogyi A, Herold M, Fodor A, Rosta K, Dank M, Lang Z, Herold Z. Does diabetes affect paraneoplastic thrombocytosis in colorectal cancer? Open Med (Wars) 2022;17:160-73. [PMID: 35071777 DOI: 10.1515/med-2021-0407] [Reference Citation Analysis]
41 Vinchhi P, Patel MM. Triumph against cancer: invading colorectal cancer with nanotechnology. Expert Opin Drug Deliv 2021;18:1169-92. [PMID: 33567909 DOI: 10.1080/17425247.2021.1889512] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
42 Jhang JS, Livneh H, Yang SY, Huang HJ, Chan MWY, Lu MC, Yeh CC, Tsai TY. Decreased risk of colorectal cancer among patients with type 2 diabetes receiving Chinese herbal medicine: a population-based cohort study. BMJ Open Diabetes Res Care 2020;8:e000732. [PMID: 32169932 DOI: 10.1136/bmjdrc-2019-000732] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
43 Zhao M, Liao D, Zhao J. Diabetes-induced mechanophysiological changes in the small intestine and colon. World J Diabetes 2017; 8(6): 249-269 [PMID: 28694926 DOI: 10.4239/wjd.v8.i6.249] [Cited by in CrossRef: 28] [Cited by in F6Publishing: 20] [Article Influence: 5.6] [Reference Citation Analysis]
44 Kato J, Shirakami Y, Yamaguchi K, Mizutani T, Ideta T, Nakamura H, Ninomiya S, Kubota M, Sakai H, Ibuka T, Tanaka T, Shimizu M. Allopurinol Suppresses Azoxymethane-Induced Colorectal Tumorigenesis in C57BL/KsJ-db/db Mice. GastrointestDisord 2020;2:385-96. [DOI: 10.3390/gidisord2040035] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
45 Overbeek JA, Kuiper JG, van der Heijden AAWA, Labots M, Haug U, Herings RMC, Nijpels G. Sex- and site-specific differences in colorectal cancer risk among people with type 2 diabetes. Int J Colorectal Dis 2019;34:269-76. [PMID: 30421309 DOI: 10.1007/s00384-018-3191-7] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.8] [Reference Citation Analysis]
46 Malik SA, Zhu C, Li J, LaComb JF, Denoya PI, Kravets I, Miller JD, Yang J, Kramer M, McCombie WR, Robertson CE, Frank DN, Li E. Impact of preoperative antibiotics and other variables on integrated microbiome-host transcriptomic data generated from colorectal cancer resections. World J Gastroenterol 2021; 27(14): 1465-1482 [PMID: 33911468 DOI: 10.3748/wjg.v27.i14.1465] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
47 Conway RBN, Peltier A, Figaro MK. Constipation and glycemic control. J Diabetes Complications 2021;35:107799. [PMID: 33303296 DOI: 10.1016/j.jdiacomp.2020.107799] [Reference Citation Analysis]
48 Karlin NJ, Amin SB, Kosiorek HE, Buras MR, Verona PM, Cook CB. Survival and glycemic control in patients with colorectal cancer and diabetes mellitus. Future Sci OA 2018;4:FSO335. [PMID: 30416744 DOI: 10.4155/fsoa-2018-0044] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 2.5] [Reference Citation Analysis]
49 Zhang J, Li G, Chen Y, Fang L, Guan C, Bai F, Ma M, Lyu J, Meng QH. Metformin Inhibits Tumorigenesis and Tumor Growth of Breast Cancer Cells by Upregulating miR-200c but Downregulating AKT2 Expression. J Cancer 2017;8:1849-64. [PMID: 28819383 DOI: 10.7150/jca.19858] [Cited by in Crossref: 25] [Cited by in F6Publishing: 27] [Article Influence: 5.0] [Reference Citation Analysis]
50 Di S, Han L, Wang Q, Liu X, Yang Y, Li F, Zhao L, Tong X. A Network Pharmacology Approach to Uncover the Mechanisms of Shen-Qi-Di-Huang Decoction against Diabetic Nephropathy. Evid Based Complement Alternat Med 2018;2018:7043402. [PMID: 30519269 DOI: 10.1155/2018/7043402] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
51 Liu Y, Wang Z, Li M, Ye Y, Xu Y, Zhang Y, Yuan R, Jin Y, Hao Y, Jiang L, Hu Y, Chen S, Liu F, Zhang Y, Wu W, Liu Y. Chloride intracellular channel 1 regulates the antineoplastic effects of metformin in gallbladder cancer cells. Cancer Sci 2017;108:1240-52. [PMID: 28378944 DOI: 10.1111/cas.13248] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 2.6] [Reference Citation Analysis]
52 Luo X, Storey S, Gandhi P, Zhang Z, Metzger M, Huang K. Analyzing the symptoms in colorectal and breast cancer patients with or without type 2 diabetes using EHR data. Health Informatics J 2021;27:14604582211000785. [PMID: 33726552 DOI: 10.1177/14604582211000785] [Reference Citation Analysis]
53 Chubak J, Yu O, Ziebell RA, Bowles EJA, Sterrett AT, Fujii MM, Boggs JM, Burnett-Hartman AN, Boudreau DM, Chen L, Floyd JS, Ritzwoller DP, Hubbard RA. Risk of colon cancer recurrence in relation to diabetes. Cancer Causes Control 2018;29:1093-103. [PMID: 30244297 DOI: 10.1007/s10552-018-1083-3] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
54 Szymańska-Chabowska A, Juzwiszyn J, Jankowska-Polańska B, Tański W, Chabowski M. Chitinase 3-Like 1, Nestin, and Testin Proteins as Novel Biomarkers of Potential Clinical Use in Colorectal Cancer: A Review. Adv Exp Med Biol 2020;1279:1-8. [PMID: 32170669 DOI: 10.1007/5584_2020_506] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
55 Singla S, Sahu C, Jena G. Association of Type 1 diabetes with ulcerative colitis in BALB/c mice: Investigations on sex-specific differences. J Biochem Mol Toxicol 2021;:e22980. [PMID: 34964214 DOI: 10.1002/jbt.22980] [Reference Citation Analysis]
56 Halamkova J, Kazda T, Pehalova L, Gonec R, Kozakova S, Bohovicova L, Slaby O, Demlova R, Svoboda M, Kiss I. The Impact of Diabetes Mellitus on the Second Primary Malignancies in Colorectal Cancer Patients. Front Oncol 2020;10:573394. [PMID: 33585194 DOI: 10.3389/fonc.2020.573394] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
57 Elek Z, Rónai Z, Keszler G, Harsányi L, Kontsek E, Herold Z, Herold M, Somogyi A, Bánlaki Z. Correlation between Expression Profiles of Key Signaling Genes in Colorectal Cancer Samples from Type 2 Diabetic and Non-Diabetic Patients. Life (Basel) 2020;10:E216. [PMID: 32971867 DOI: 10.3390/life10090216] [Reference Citation Analysis]
58 Fakharzadeh S, Argani H, Dadashzadeh S, Kalanaky S, Mohammadi Torbati P, Nazaran MH, Basiri A. BCc1 Nanomedicine Therapeutic Effects in Streptozotocin and High-Fat Diet Induced Diabetic Kidney Disease. Diabetes Metab Syndr Obes 2020;13:1179-88. [PMID: 32368111 DOI: 10.2147/DMSO.S240757] [Reference Citation Analysis]
59 Kato J, Shirakami Y, Shimizu M. Diabetes Mellitus and Colon Carcinogenesis: Expectation for Inhibition of Colon Carcinogenesis by Oral Hypoglycemic Drugs. GastrointestDisord 2019;1:273-89. [DOI: 10.3390/gidisord1020023] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
60 Besic N, Povsic MK. Long term survival in 200 patients with advanced stage of colorectal carcinoma and diabetes mellitus - a single institution experience. Radiol Oncol 2019;53:238-44. [PMID: 31104000 DOI: 10.2478/raon-2019-0022] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
61 Smit JA, Baas JM, Verheijen PM. Metastasis of colorectal carcinoma in the testis: first sign of peritoneal disease. J Surg Case Rep 2019;2019:rjz270. [PMID: 31687127 DOI: 10.1093/jscr/rjz270] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
62 Lawler M, Alsina D, Adams RA, Anderson AS, Brown G, Fearnhead NS, Fenwick SW, Halloran SP, Hochhauser D, Hull MA, Koelzer VH, McNair AGK, Monahan KJ, Näthke I, Norton C, Novelli MR, Steele RJC, Thomas AL, Wilde LM, Wilson RH, Tomlinson I; Bowel Cancer UK Critical Research Gaps in Colorectal Cancer Initiative. Critical research gaps and recommendations to inform research prioritisation for more effective prevention and improved outcomes in colorectal cancer. Gut 2018;67:179-93. [PMID: 29233930 DOI: 10.1136/gutjnl-2017-315333] [Cited by in Crossref: 52] [Cited by in F6Publishing: 41] [Article Influence: 13.0] [Reference Citation Analysis]
63 Li M, Wang S, Han X, Liu W, Song J, Zhang H, Zhao J, Yang F, Tan X, Chen X, Liu Y, Li H, Ding Y, Du X, Yin J, Zhang R, Cao G. Cancer mortality trends in an industrial district of Shanghai, China, from 1974 to 2014, and projections to 2029. Oncotarget 2017;8:92470-82. [PMID: 29190931 DOI: 10.18632/oncotarget.21419] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
64 Peng F, Hu D, Lin X, Chen G, Liang B, Chen Y, Li C, Zhang H, Xia Y, Lin J, Zheng X, Niu W. An in-depth prognostic analysis of baseline blood lipids in predicting postoperative colorectal cancer mortality: The FIESTA study. Cancer Epidemiol 2018;52:148-57. [PMID: 29324354 DOI: 10.1016/j.canep.2018.01.001] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
65 Kaneko H, Yano Y, Itoh H, Morita K, Kiriyama H, Kamon T, Fujiu K, Michihata N, Jo T, Takeda N, Morita H, Nishiyama A, Node K, Bakris G, Miura K, Muntner P, Viera AJ, Oparil S, Lloyd-Jones DM, Yasunaga H, Komuro I. Untreated Hypertension and Subsequent Incidence of Colorectal Cancer: Analysis of a Nationwide Epidemiological Database. J Am Heart Assoc 2021;10:e022479. [PMID: 34724797 DOI: 10.1161/JAHA.121.022479] [Reference Citation Analysis]
66 Mühl D, Herold M, Herold Z, Hornyák L, Szasz AM, Dank M. Longitudinal Analysis of 1α,25-dihidroxyvitamin D3 and Homocysteine Changes in Colorectal Cancer. Cancers (Basel) 2022;14:658. [PMID: 35158926 DOI: 10.3390/cancers14030658] [Reference Citation Analysis]
67 Kato J, Shirakami Y, Mizutani T, Kubota M, Sakai H, Ibuka T, Shimizu M. Alpha-Glucosidase Inhibitor Voglibose Suppresses Azoxymethane-Induced Colonic Preneoplastic Lesions in Diabetic and Obese Mice. Int J Mol Sci 2020;21:E2226. [PMID: 32210144 DOI: 10.3390/ijms21062226] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
68 Gillies RJ, Pilot C, Marunaka Y, Fais S. Targeting acidity in cancer and diabetes. Biochim Biophys Acta Rev Cancer. 2019;1871:273-280. [PMID: 30708040 DOI: 10.1016/j.bbcan.2019.01.003] [Cited by in Crossref: 27] [Cited by in F6Publishing: 30] [Article Influence: 9.0] [Reference Citation Analysis]
69 Del Puerto-Nevado L, Minguez P, Corton M, Solanes-Casado S, Prieto I, Mas S, Sanz AB, Gonzalez-Alonso P, Villaverde C, Portal-Nuñez S, Aguilera O, Gomez-Guerrero C, Esbrit P, Vivanco F, Gonzalez N, Ayuso C, Ortiz A, Rojo F, Egido J, Alvarez-Llamas G, Garcia-Foncillas J; DiabetesCancerConnect Consortium. Molecular evidence of field cancerization initiated by diabetes in colon cancer patients. Mol Oncol 2019;13:857-72. [PMID: 30628165 DOI: 10.1002/1878-0261.12438] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
70 Cheng HC, Chang TK, Su WC, Tsai HL, Wang JY. Narrative review of the influence of diabetes mellitus and hyperglycemia on colorectal cancer risk and oncological outcomes. Transl Oncol 2021;14:101089. [PMID: 33838541 DOI: 10.1016/j.tranon.2021.101089] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
71 Laskar J, Bhattacharjee K, Sengupta M, Choudhury Y. Anti-Diabetic Drugs: Cure or Risk Factors for Cancer? Pathol Oncol Res 2018;24:745-55. [DOI: 10.1007/s12253-018-0402-z] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
72 Cui G, Huang Y, Feng W, Yao Y, Zhou H, Li X, Gong H, Liu J, Luo Y, Sun Y, Zhang M, Luo Y, Zhang T. Colon cancer-associated transcript-1 enhances glucose metabolism and colon cancer cell activity in a high-glucose environment in vitro and in vivo. J Gastrointest Oncol 2020;11:1164-85. [PMID: 33456991 DOI: 10.21037/jgo-20-474] [Reference Citation Analysis]
73 Xu B, Li S, Lv W, Wang Y, Li X, Zhang L, Lin J. Transcriptomic analysis reveals the underlying pro-malignant functions of Gankyrin for colorectal cancer via affecting tumor necrosis factor pathway. Int J Biol Macromol 2018;117:1011-6. [PMID: 29883699 DOI: 10.1016/j.ijbiomac.2018.06.012] [Reference Citation Analysis]
74 Mehrzad J, Dayyani M, Erfanian-Khorasani M. The independent and combined effects of selected risk factors and Arg399Gln XRCC1 polymorphism in the risk of colorectal cancer among an Iranian population. Med J Islam Repub Iran 2020;34:75. [PMID: 33306066 DOI: 10.34171/mjiri.34.75] [Reference Citation Analysis]
75 Kattar SA, Jurjus R, Pinon A, Leger DY, Jurjus A, Boukarim C, Diab-Assaf M, Liagre B. Metformin and Probiotics in the Crosstalk between Colitis-Associated Colorectal Cancer and Diabetes in Mice. Cancers (Basel) 2020;12:E1857. [PMID: 32664279 DOI: 10.3390/cancers12071857] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
76 Amable G, Martínez-León E, Picco ME, Di Siervi N, Davio C, Rozengurt E, Rey O. Metformin inhibits β-catenin phosphorylation on Ser-552 through an AMPK/PI3K/Akt pathway in colorectal cancer cells. Int J Biochem Cell Biol 2019;112:88-94. [PMID: 31082618 DOI: 10.1016/j.biocel.2019.05.004] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 4.0] [Reference Citation Analysis]
77 Bonagiri PR, Shubrook JH. Review of Associations Between Type 2 Diabetes and Cancer. Clin Diabetes 2020;38:256-65. [PMID: 32699474 DOI: 10.2337/cd19-0077] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
78 Kelty E, Ward SV, Cadby G, McCarthy NS, O'Leary P, Moses EK, Ee HC, Preen DB. Familial and non-familial risk factors associated with incidence of colorectal cancer in young and middle-aged persons in Western Australia. Cancer Epidemiol 2019;62:101591. [PMID: 31494463 DOI: 10.1016/j.canep.2019.101591] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
79 Nowak-Sliwinska P, Scapozza L, Ruiz i Altaba A. Drug repurposing in oncology: Compounds, pathways, phenotypes and computational approaches for colorectal cancer. Biochim Biophys Acta Rev Cancer 2019;1871:434-54. [PMID: 31034926 DOI: 10.1016/j.bbcan.2019.04.005] [Cited by in Crossref: 67] [Cited by in F6Publishing: 55] [Article Influence: 22.3] [Reference Citation Analysis]
80 Troelsen FS, Sørensen HT, Pedersen L, Erichsen R. Risk of a post-colonoscopy colorectal cancer in patients with type 2 diabetes: a Danish population-based cohort study. BMJ Open Gastroenterol 2021;8:e000786. [PMID: 34952850 DOI: 10.1136/bmjgast-2021-000786] [Reference Citation Analysis]